ROCHESTER, N.Y., May 14, 2009 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N), a developer of extended release technologies and supplier of polymer additives based on naturally occurring nanomaterials, is featured in an interview by Wall Street Transcript. The interview will appear in the May 18th issue. Commenting on the interview, Mr. Wemett, said, "We are pleased that The Wall Street Transcript has chosen to feature NaturalNano in its May 18th issue and on their website. This increased attention being paid to NaturalNano's controlled release HNT technology, Halloysite Natural Tubular products and their market potential plus our extensive patent portfolio is exciting."
About NaturalNano, Inc.:
Headquartered in Rochester, NY, NaturalNano, Inc. (OTCBB:NNAN) (Frankfurt:N3N) develops and commercializes products and solutions for extended release attributes for consumer goods as well as polymer additives based on naturally occurring nanomaterials from halloysite The Company offers its proprietary Pleximer(tm) line of additives for industrial polymers, plastics and composites. NaturalNano holds and licenses more than 25 patents and its applications, as well as proprietary know-how for extraction, classification, and modification of non-toxic and environmentally friendly halloysite natural tubules (HNT). For more information, visit http://www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: This press release may contain forward-looking statements regarding future events and future performance of NaturalNano that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.